Speaker(s): 

Travis Taylor, MD, Physician, Geisinger - has nothing to disclose.

Learning Objectives:

• examine one or both trials in terms of trial design and applicability to our practice
• evaluate recent data from one or both trials presented at ISC in regard to extending the thrombolysis window

At the conclusion of this session, the participant should be able to: 

• are the data/conclusions generalizable to our patient population?
• should this change our practice at Geisinger?
• if this should change out practice - how do we as a group enact said changes?

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Anthony Noto, MD, David Ermak, DO, Lisa Wasko, BSN, RN, SCRN have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None